相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 免疫原:
该BioSIM 抗人 CD140b/PDGFRB 抗体 (利努苏单抗),生物类似药,科研用途 [ CAS: 1569263-06-4]的免疫原请参考该产品的说明书
- 保存条件:
为确保适当储存,请避免反复冻融。短期需求(1-2周)请在4°C下保存;最长12个月的储存请在-20°C下保存。长期储存请在-80°C下保存。
- 克隆性:
单克隆
- 适应物种:
Human
- 保质期:
为确保适当储存,请避免反复冻融。短期需求(1-2周)请在4°C下保存;最长12个月的储存请在-20°C下保存。长期储存请在-80°C下保存。
- 级别:
科研级别
- 库存:
999
- 供应商:
亚科因(Abbkine)
- 宿主:
Human
- 应用范围:
ELISA, FACS, Functional assay, Research in vivo
- 抗体英文名:
CD140b/PDGFRB
- 抗体名:
CD140b/PDGFRB
- 规格:
1mg
BioSIM anti-Human CD140b/PDGFRB Antibody (Rinucumab Biosimilar)
中文名称:BioSIM 抗人 CD140b/PDGFRB 抗体 (利努苏单抗),生物类似药,科研用途
核心参数
- 产品货号:SIM0803-1mg
- 产品规格:1mg
- CAS号:1569263-06-4
- 供应商:InvivoCrown
- 抗体类型:一抗 (注:根据其靶向特定抗原的特性,推断为一抗)
- 来源宿主:Human
- 反应性:Human
产品概述
本产品是一款科研级别的利努苏单抗 生物类似药,专为靶向人源CD140b/PDGFRB(血小板衍生生长因子受体β)而设计。该抗体在无动物成分的设施中,采用先进的体外无蛋白细胞培养技术进行生产,并经过包含Protein A/G亲和层析在内的多步骤纯化工艺,以确保产品的批次一致性和高纯度。
应用领域
本产品是进行相关生命科学研究的理想工具,主要应用于以下领域:
- 研究方向:年龄相关性黄斑变性 (AMD)、湿性黄斑变性 (wAMD) 等血管生成相关疾病的研究。
- 应用类型:ELISA、流式细胞术 (FACS)、功能性分析、体内研究。
产品特性
- 生物类似药设计:作为利努苏单抗的生物类似药,本产品旨在提供与参考抗体相似的结合特性和生物学功能,为科研工作提供可靠且经济的选择。
- 高纯度生产工艺:通过多步纯化流程,特别是Protein A/G色谱技术,有效去除杂质,保障实验结果的准确性。
- 无动物源生产体系:生产过程不涉及任何动物源性成分,降低了外源因子(如病毒、支原体)污染的风险,同时提高了产品批次间的稳定性。
- 人源化抗体:抗体来源于人源宿主,可减少在动物模型或细胞实验中的非特异性反应,提高实验的相关性。
储存与处理
为确保产品活性,请遵循以下储存建议:
- 短期储存:对于1-2周内使用的抗体,可于4°C条件下保存。
- 长期储存:推荐在-20°C下保存,有效期最长可达12个月。为达到最佳长期稳定性,建议储存于-80°C。
- 重要提示:请务必避免反复冻融,建议分装后保存。
重要声明
请注意:本产品为科研级别试剂,仅用于实验室研究目的,不得用于诊断、治疗或任何人体应用。
注意:以上信息可能随着产品优化升级等因素产生变动,具体信息请咨询亚科因公司。

BioSIM anti-Human CD140b/PDGFRB Antibody (Rinucumab Biosimilar)
Chinese Name: BioSIM anti-Human CD140b/PDGFRB Antibody (Rinucumab Biosimilar), for Research Use
Core Parameters
- Product Number: SIM0803-1mg
- Product Specification: 1mg
- CAS Number: 1569263-06-4
- Supplier: InvivoCrown
- Antibody Type: Primary Antibody (Note: Inferred as primary antibody based on its targeting of specific antigens)
- Source Host: Human
- Reactivity: Human
Product Overview
This product is a research-grade Rinucumab Biosimilar specifically designed to target human CD140b/PDGFRB (Platelet-Derived Growth Factor Receptor beta). The antibody is produced in animal-free facilities using advanced animal-free cell culture technology and undergoes a multi-step purification process including Protein A/G affinity chromatography to ensure batch consistency and high purity.
Application Areas
This product is an ideal tool for conducting related life science research, mainly used in the following fields:
- Research Areas: Studies on angiogenesis-related diseases such as Age-related Macular Degeneration (AMD), Wet Macular Degeneration (wAMD).
- Application Types: ELISA, Flow Cytometry (FACS), Functional Analysis, In Vivo Studies.
Product Features
- Biosimilar Design: As a biosimilar of Rinucumab, this product aims to provide similar binding characteristics and biological functions as the reference antibody, offering a reliable and economical choice for research work.
- High-Purity Production Process: Through multi-step purification processes, especially Protein A/G chromatography, impurities are effectively removed to ensure the accuracy of experimental results.
- Animal-Free Production System: The production process does not involve any animal-derived components, reducing the risk of contamination by exogenous factors (such as viruses, mycoplasma) while improving the stability between product batches.
- Humanized Antibody: The antibody is derived from a human source host, which can reduce non-specific reactions in animal models or cell experiments and improve the relevance of experiments.
Storage and Handling
To ensure product activity, please follow the following storage recommendations:
- Short-term Storage: For antibodies to be used within 1-2 weeks, they can be stored at 4°C.
- Long-term Storage: It is recommended to store at -20°C, with a validity period of up to 12 months. For optimal long-term stability, storage at -80°C is recommended.
- Important Note: Please avoid repeated freeze-thaw cycles; aliquoting before storage is recommended.
Important Statement
Please Note: This product is a research-grade reagent and is intended for laboratory research purposes only. It must not be used for diagnosis, treatment, or any human applications.
Note: The information above may change due to factors such as product optimization and upgrades. For specific information, please consult Yacoin Company.
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验该药)5、我国单克隆抗体药物研发进展情况近年来中国的单抗技术已经受到越来越多的关注和重视,单克隆抗体药物研究已被列入863计划和国家重点攻关项目。目前,中国已有2个治疗性单抗产品获准生产,3个治疗性产品处在临床试验阶段,多个抗体药物处于临床前研究阶段,已批准的诊断性单抗有31个。武汉生物制品研究所抗肾移植单抗OKT3(注射用鼠源性抗人T淋巴细胞CD3抗原单克隆抗体)最早批准上市,具有免疫抑制作用,可逆转对移植器官的排斥反应。东莞宏远逸士生物技术药业开发的生物制品国家一类新药:粤宏远(0573)下属
。比如,用荧光素或藻红素标记的抗CD4的RNA配基,在流式细胞仪上检测细胞表面表达的CD4分子。3、传感器传感器由于能快速、简便且定量检测而受到重视,但抗体介导的免疫传感器的重复使用受限,需要温和的条件以免破坏抗体的功能。而核酸配基可以在热、不同盐浓度、金属螯和剂等条件下反复变性和复性,可修饰和固化,容易标记报告基团。已有荧光标记的抗人凝血素核酸配基用于体内诊断的报道。这种传感器的另一个优点是不需要对靶分子进行标记,还可以用于体内诊断。4、荧光偏振在基于荧光偏振原理的小分子激素类的简便快速检测方法中,采用
检验中,此法适用于检验各种蛋白质等大分子抗原,例如HBsAg、HBeAg、AFP、hCG等。只要获得针对受检抗原的特异性抗体,就可用于包被固相载体和制备酶结合物而建立此法。如抗体的来源为抗血清,包被和酶标用的抗体最好分别取自不同种属的动物。如应用单克隆抗体,一般选择两个针对抗原上不同决定簇的单抗,分别用于包被固相载体和制备酶结合物。这种双位点夹心法具有很高的特异性,而且可以将受检标本和酶标抗体一起保温反应,作一步检测。在一步法测定中,当标本中受检抗原的含量很高时,过量抗原分别和固相抗体及酶标抗体
技术资料暂无技术资料 索取技术资料







